Update shared on 28 Oct 2025
Fair value Increased 0.08%Analysts have marginally increased their price target for China Literature to RMB 39.17 from RMB 39.14, citing stable expectations for revenue growth and profit margins.
What's in the News
- From January 1, 2025 to May 30, 2025, China Literature repurchased 6,138,800 shares, representing 0.6% of its total shares for HKD 152.84 million. This contributed to a total completed buyback of 13,865,800 shares, or 1.36% of shares, for HKD 422.78 million under the buyback program announced on June 21, 2024 (Key Developments).
- Between June 2, 2025 and June 30, 2025, the company repurchased an additional 200,000 shares, representing 0.02% for HKD 5.18 million, as part of the buyback program announced on June 2, 2025 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has risen slightly to RMB 39.17 from RMB 39.14.
- Discount Rate remains effectively unchanged at 6.89%.
- Revenue Growth forecast is stable at approximately 8.31%.
- Net Profit Margin projection is steady at about 19.09%.
- Future P/E has decreased marginally to 25.04x from 25.12x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.